Patents by Inventor Ethel Garnier-Amblard

Ethel Garnier-Amblard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOW TEMPERATURE STABLE FORMULATIONS OF UREASE INHIBITOR-CONTAINING COMPOSITIONS
    Publication number: 20200022372
    Abstract: The present disclosure relates to formulations comprising a urease inhibitor with improved stability against crystallization and/or freezing upon exposure to low temperatures, such as for example, 0° C. or below. The present disclosure also provides methods to make and use such a formulation.
    Type: Application
    Filed: July 18, 2019
    Publication date: January 23, 2020
    Inventors: Ethel Garnier-Amblard, Douglas Barr
  • 2',2'-DIHALO NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER
    Publication number: 20170334941
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing Flaviviridae family of viruses (including HCV, Yellow fever, Dengue, Chikungunya Ebola and West Nile virus), RSV, HEV, and influenza infection and cancer in human subjects or other animal hosts.
    Type: Application
    Filed: October 30, 2015
    Publication date: November 23, 2017
    Inventors: Steven J. Coats, Franck Amblard, Ethel Garnier-Amblard, Raymond F. Schinazi